Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Leadermed Champion Limited is managing 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This active case is located within 1 distinct art unit, reflecting a specific technical niche for the company's current intellectual property. The prosecution process involves 1 distinct examiner, which simplifies the administrative oversight required for the portfolio. A centralized point of contact at the patent office can lead to a more consistent prosecution experience.
The busiest examiner for this company is GULLEDGE, BRIAN M, who is currently assigned 1 pending office action. Because there is only 1 distinct examiner and 1 distinct art unit, the prosecution strategy is entirely dependent on the interaction with GULLEDGE, BRIAN M. This focus within the Biotechnology & Pharmaceuticals area allows for a targeted approach to resolving the 1 pending action and advancing the patent application. The company does not face the challenge of managing different examiner expectations across multiple distinct art units.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GULLEDGE, BRIAN M | 1 | 55.8% | +26.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18681240 | miRNA-BASED COMPOSITIONS AND METHODS OF USE THEREOF | GULLEDGE, BRIAN M | 1d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18681240 | miRNA-BASED COMPOSITIONS AND METHODS OF USE THEREOF | GULLEDGE, BRIAN M | 1d overdue |
| Art Unit | Apps |
|---|---|
| 1699 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18681240 | miRNA-BASED COMPOSITIONS AND METHODS OF USE THEREOF | GULLEDGE, BRIAN M | 1699 | §101§102§103§112 | Non-Final OA | 1d overdue | Pending | Feb 05, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial